Merck & Company June 15th Short Interest Update

Merck & Company (NYSE:MRK) has shown a rise of 4.9% or 1,437,856 shares in the short positions. The bets have increased to 30,994,348 shares on June 15,2016 from 29,556,492 shares on May 31,2016. With respect to the floated shares, the shorts are 1.1%. The days to cover are calculated to be 4, using the standard per day volume of 7,416,099 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

Merck & Company (NYSE:MRK): The stock opened at $56.04 on Friday but the bulls could not build on the opening and the stock topped out at $57.07 for the day. The stock traded down to $55.77 during the day, due to lack of any buying support eventually closed down at $55.88 with a loss of -3.12% for the day. The stock had closed at $57.68 on the previous day. The total traded volume was 17,258,559 shares.

The company shares have dropped -2.46% from its 1 Year high price. On Aug 19, 2015, the shares registered one year high at $60.07 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $55.85 and the 200 Day Moving Average price is recorded at $53.42.

Merck & Company (NYSE:MRK) has tumbled 0.02% during the past week and has dropped 1.06% in the last 4 week period. In the past week, the company has outperformed the S&P 500 by 1.64% and the outperformance has advanced to 1.93% for the last 4 weeks period.

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures. The Companys Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. The Companys animal health products are sold to veterinarians, distributors and animal producers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.